“The Double-Dare of Cholesterol: Why Indian Patients Need Both LDL and ApoB to Outwit Heart & Kidney Risk ”. Diabzen, vol. 3, no. 2, Nov. 2025, pp. 35-38, https://www.thediabzen.com/index.php/d/article/view/17.